Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03419468 · ClinicalTrials.gov registry record · NA
LCI-GER-NOS-TAB-001: Tablet for Geriatric Assessment
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT03419468 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 89 participants.
The verdict
NCT03419468, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The Self Geriatric Assessment Measure \[SGAM\] is based on a standard diagnostic tool used to evaluate geriatric cancer patients in order to determine the appropriateness of cancer directed therapy at LCI. This questionnaire has sections that matches portions of a self-administered geriatric assessment in patients aged 70 or older with malignancy. The prolonged duration of time needed to complete the assessment makes its performance less feasible in standard practice settings. In previously published studies the Cancer Specific Geriatric Assessment (CSGA) has been provided both via written questionnaire and by personal computer in subjects 70 years of age or older. With improvements in technology, the goal is to evaluate the feasibility of administering the SGAM via an iPad tablet and compare results to both gold standard paper format and prior desktop computer data. This study proposes the use of an iPad tablet to administer the SGAM may help: Improve the completion rate of the SGAM assessment Reduction in the time of completion Improvement in the accuracy of reporting
Interventions
- OTHER Self Geriatric Assessment Measure (SGAM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2018-01-12 |
| Est. Completion | 2019-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03419468
The ClinicalTrials.gov registry entry for NCT03419468 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Self Geriatric Assessment Measure (SGAM) is the first listed.
NCT03419468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03419468 about?
NCT03419468 is a clinical study titled "LCI-GER-NOS-TAB-001: Tablet for Geriatric Assessment". The Self Geriatric Assessment Measure \[SGAM\] is based on a standard diagnostic tool used to evaluate geriatric cancer patients in order to determine the appropriateness of cancer directed therapy at LCI. This questionnaire has sections that matches portions of a self-administered geriatric assessm...
What is the current status of trial NCT03419468?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2018-01-12. Estimated completion is 2019-11-18.
What interventions are being tested in trial NCT03419468?
The interventions under investigation include: Self Geriatric Assessment Measure (SGAM) (OTHER).
Who is sponsoring clinical trial NCT03419468?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.